{"id":"W4411453748","doi":"10.1080/14796694.2025.2513219","title":"Plain language summary of the ECHELON-3 study: brentuximab vedotin combination treatment in people with diffuse large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"BeiGene; Sanofi; AstraZeneca; Pfizer","keywords":"Brentuximab vedotin; Medicine; Oncology; Internal medicine; Lymphoma; Diffuse large B-cell lymphoma; Medical physics; Hodgkin lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000133488,0.0001853216,0.0004973185,0.0001359182,0.00006411738,0.000006001591,0.0001024546,0.0001338384,0.00002366006],"category_scores_gemma":[0.0000154603,0.0001039539,0.00008611921,0.0003925739,0.00003512307,0.00002448045,0.00006445669,0.00006896035,0.000006075865],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001150258,"about_ca_system_score_gemma":0.0005326011,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008551398,"about_ca_topic_score_gemma":0.01270448,"domain_scores_codex":[0.9988989,0.0001940425,0.0002548188,0.0002642498,0.0001595002,0.0002284715],"domain_scores_gemma":[0.999249,0.0001627378,0.0001193254,0.0003814998,0.00004361139,0.00004386708],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009104252,0.1021123,0.8672718,0.0000788909,0.0002386726,0.0002974874,0.006986972,9.129651e-7,0.000226744,0.0006842356,0.001637658,0.01955379],"study_design_scores_gemma":[0.09065834,0.003632617,0.881723,0.00008937989,0.0003467021,0.00001945237,0.007952477,0.00002963359,0.003620082,0.00001251703,0.01182684,0.00008891594],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863269,0.0009172781,0.000001997609,0.003089987,0.0002974047,0.00141738,0.00002633928,0.00002435049,0.00789834],"genre_scores_gemma":[0.997282,0.00009789517,0.00005738435,0.0004088674,0.00006049231,0.0002759292,0.00006542254,0.00001309806,0.001738916],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09847973,"threshold_uncertainty_score":0.7089399,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004727756126626704,"score_gpt":0.2676412565808298,"score_spread":0.2629135004542031,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}